fluorodeoxyglucose f18 has been researched along with Small Cell Lung Carcinoma in 105 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (9.52) | 29.6817 |
2010's | 74 (70.48) | 24.3611 |
2020's | 21 (20.00) | 2.80 |
Authors | Studies |
---|---|
Goksel, S; Ozcelik, N | 1 |
Dittmann, H; Schwenck, J; Solass, W; Tenev, A; Vogel, J | 1 |
Bennett, P | 1 |
Cui, Y; Ji, Y; Shao, C; Shao, G; Su, N; Wang, Y; Zheng, J | 1 |
Aras, F; Olmezoglu, A | 1 |
Aloglu, M; Atikcan, Ş; Çimen, F; Düzgün, S; Özmen, Ö; Şentürk, A | 1 |
Bülbül, HM; Bülbül, O; Çapa Kaya, G; Gezer, NS; Gürel, D; Tertemiz, KC; Ulukuş, EÇ | 1 |
Fukui, Y; Hamamoto, Y; Isogai, T; Takahashi, M | 1 |
Bund, C; Mennecier, B; Namer, IJ; Ouvrard, E; Voulleminot, P | 1 |
Nakahira, S; Oi, K; Saito, Y; Tamagawa, H; Taniguchi, E; Tsujimura, N | 1 |
Erturk, K; Ozturk, A; Tas, F | 1 |
Aigner, C; Darwiche, K; Eberhard, W; Hautzel, H; Herrmann, K; Hockmann, J; Plönes, T; Stuschke, M | 1 |
Huang, W; Kang, L; Qiu, Y; Tao, Z; Wang, A | 1 |
Capoccetti, F; Castagnoli, H; Fattori, S; Manni, C; Marchesani, F; Rossi, G | 1 |
Choi, EK; Chung, YA; Im, JJ; Oh, JK; Park, M | 1 |
Khan, U; Warriach, SA | 1 |
Cheon, GJ; Chung, JH; Kang, KW; Kang, SY; Kim, DW; Kim, HJ; Seo, YS; Wu, HG | 1 |
Eshghi, N; Garland, LL; Hamilton, RJ; Hsu, C; Kuo, PH; Sawyer, DM; Sawyer, TW | 1 |
Benedetti, L; Filippi, L; Massa, F; Morbelli, S; Nobili, F | 1 |
Alongi, P; Caobelli, F; Chiaravalloti, A; Cistaro, A; Evangelista, L; Laudicella, R; Quartuccio, N; Salem, A; Spataro, A | 1 |
Flamini, MEDM; Flamini, RC; Mota, IA; Verçosa, AFA | 1 |
Aktan, M; Kanyilmaz, G; Koc, M; Yavuz, BB | 1 |
Bol, A; Di Perri, D; Geets, X; Hanin, FX; Janssens, G; Labar, D; Lee, JA; Robert, A; Sterpin, E | 1 |
Fu, Z; Han, A; Jin, F; Kong, L; Qu, B; Yu, J; Zhang, Y | 1 |
Cooper, AZ; Frosch, ZA; Ma, C; Overmoyer, B | 1 |
Dong, X; Duan, Q; Jiang, R; Shen, Y; Xue, Y; Zhang, G; Zhu, W | 1 |
Hou, S; Jiao, B; Lin, C; Sa, R; Xu, S; Zhao, H | 1 |
Ding, CY; Guo, Z; Li, TR; Li, YY | 1 |
Bu, H; Cui, J; Gao, R; Guo, X; Han, W; He, J; Li, Q; Li, X; Zhao, Z; Zou, Y | 1 |
Byanju, S; Chen, J; Liao, M; Wang, L; Wang, Y; Zhang, H; Zhu, D | 1 |
Hyun, IY; Lee, M; Ryu, JS; Suh, CH | 1 |
Choi, JS; Lee, JW; Lee, SM; Lyu, J | 1 |
Itoh, T; Kishida, Y; Maniwa, Y; Nishimura, Y; Ohno, Y; Seki, S; Yoshikawa, T | 1 |
Buyuksimsek, M; Gokcay, S; Guney, IB; Kapukaya, TK; Karaalioglu, B; Mirili, C; Ogul, A; Paydas, S; Seydaoglu, G; Tohumcuoglu, M; Yetisir, AE | 1 |
Hasegawa, G; Hoshi, T; Kanefuji, T; Kobayashi, M; Morita, S; Oda, C; Suda, T; Terai, S; Yagi, K | 1 |
Chen, YN; Liu, SY; Nie, K; Nie, W; Xiao, YX; Yu, H; Zhang, YX; Zhu, L | 1 |
Beyzadeoglu, M; Demiral, S; Dincoglan, F; Dirican, B; Elcim, Y; Gamsiz, H; Gundem, E; Sager, O; Uysal, B | 1 |
Fukushima, T; Gomi, D; Kobayashi, T; Koizumi, T; Oguchi, K; Sekiguchi, N | 1 |
Alongi, P; Altini, C; Asabella, AN; Baldari, S; Caobelli, F; Cardile, D; Chiaravalloti, A; Ciaccio, A; Cistaro, A; Cuppari, L; Di Pierro, G; Evangelista, L; Fanti, S; Kokomani, A; Lambertini, A; Laudicella, R; Lima, GM; Linguanti, F; Margotti, S; Pacella, S; Panareo, S; Popescu, CE; Quartuccio, N; Rubini, G; Scalisi, S; Scalorbi, F; Schillaci, O; Schiorlin, I; Sturiale, L; Vento, A | 1 |
Araz, M; Gönüllü, U; Kir, KM; Kucuk, ON; Nak, D; Özkan, E; Sen, E; Soydal, C | 1 |
El Badaoui, A; Hitzel, A; Melloni, B; Monteil, J; Wagner, T; Woillard, JB; Ziai, D | 1 |
Ahn, JS; Ahn, MJ; Choi, JY; Chung, MP; Han, J; Jeon, K; Jhun, BW; Kim, H; Kwon, OJ; Lee, KJ; Lee, KS; Park, K; Suh, GY; Sun, JM; Um, SW | 1 |
Brocken, P; de Geus-Oei, LF; Dekhuijzen, PN; Peters-Bax, L; van der Heijden, HF | 1 |
Apisarnthanarax, S; Christodouleas, JP; Corradetti, MN; Evans, TL; Fernandes, AT; Grover, S; Kim, M; Langer, CJ; Lee, TT; Lin, LL; Mitra, N; Pryma, DA; Rengan, R; Simone, CB; Stevenson, JP; Xanthopoulos, EP | 1 |
Carozzi, FM; Carrozzi, L; Comin, C; Deliperi, A; Falaschi, F; Falchini, M; Grazzini, M; Innocenti, F; Lopes Pegna, A; Maddau, C; Mascalchi, M; Paci, E; Picozzi, G; Pistelli, F; Vaggelli, L; Vella, A | 1 |
Boomsma, MF; Stigt, JA; van Bemmel, BC | 1 |
Ahn, BC; Bom, HS; Hong, CM; Jeong, SY; Kim, YC; Lee, J; Lee, SW; Min, JJ; Oh, JR; Seo, JH; Song, HC | 1 |
Petrun'kin, AM; Tlostanova, MS | 1 |
Jain, S; Karunanithi, S; Kumar, R; Mukherjee, A; Sharma, P | 1 |
Choi, BH; Chung, SI; Go, SI; Hwang, IG; Jung, J; Kang, JH; Kang, MH; Kim, MJ; Kim, SH; Lee, GW; Ling, H; Song, HN | 1 |
Choi, WH; Chun, SH; Hong, SH; Jeon, EK; Jung, CK; Kang, JH; Kim, JO; Kim, SJ; Kim, YK; Kim, YS; Lee, J; Yoo, IeR | 1 |
Carrasquillo, JA; Downey, RJ; Panicek, DM; Shia, J; Strong, VE; Untch, BR | 1 |
Bansal, P; Behera, D; Gupta, A; Gupta, N; Maturu, VN; Rai Mittal, B; Singh, N | 1 |
Chen, JH; Chu, S; Kao, CH; Liang, JA; Lin, WY; Lu, YY | 1 |
Cho, J; Choi, NC; Sharp, GC; Shusharina, N | 1 |
Akgun, M; Araz, O; Calik, M; Daloglu, F; Demirci, E; Durur-Subasi, I; Karaman, A; Orsal, E; Subasi, M; Ucar, EY | 1 |
Hugo, G; Saraiya, S; Weiss, E | 1 |
Choi, NC; Sharp, GC; Shusharina, N | 1 |
Ahn, MJ; Ahn, YC; Choi, JY; Kim, BT; Kim, H; Moon, SH; Park, K; Park, SB; Yoo, J | 1 |
Barber, PV; Booton, R; Califano, R; Crosbie, PA; Evison, M; Martin, J; Summers, Y | 1 |
Araki, T; Koizumi, K; Nambu, A; Satoh, Y | 1 |
Dunphy, M; Foster, A; Gelblum, DY; Ong, LT; Perez, CA; Pietanza, CM; Rimner, A; Rosenzweig, KE; Woo, KM; Wu, AJ; Zhang, Z | 1 |
Baillet, C; Béron, A; Frimat, M; Gnemmi, V; Huglo, D; Jaillard, A; Noël, C; Perbet, R; Scherpereel, A; Tabibzadeh, N | 1 |
Allen, AM; Bernstine, H; Domachevsky, L; Flex, D; Groshar, D; Nidam, M; Rapson, Y; Stemmer, SM; Zer, A | 1 |
Ishimori, T; Kim, YH; Koyasu, S; Kubo, T; Nakamoto, Y; Nobashi, T; Togashi, K; Yoshizawa, A | 1 |
Buck, AK; Herrmann, K; Kropf, S; Lapa, C; Lückerath, K; Pelzer, T; Rudelius, M; Samnick, S; Schirbel, A; Schmid, JS; Schoene, A; Wester, HJ | 1 |
An, YS; Choi, JH; Hyun, SH; Kwon, SH; Lee, SJ; Oh, YT; Park, KJ; Yoon, JK | 1 |
Biner Uslu, I; Dikmen, A; Erdoğan, Y; Yilmaz Demirci, N; Yılmaz, A; Yilmaz, Ü | 1 |
Dai, D; Li, X; Men, X; Song, X; Wang, J; Xu, W; Yu, X; Zhu, L; Zhu, Y | 1 |
Carrozzi, L; Comin, C; Falaschi, F; Grazzini, M; Innocenti, F; Lopes Pegna, A; Maria Carozzi, F; Mascalchi, M; Paci, E; Picozzi, G; Ronchi, C; Spinelli, C | 1 |
Delaloye, AB; Letovanec, I; Martins Favre, M; Orcurto, MV; Prior, JO | 1 |
Cheng, Z; He, J; Lin, L; Liu, L; Mao, YS; Zheng, R | 1 |
Chang, J; Cho, A; Cho, BC; Choi, HJ; Kim, JH; Kim, SK; Lee, YJ; Moon, JW; Park, IK; Yun, M | 1 |
Kleinig, TJ; Kneebone, CS; Thompson, PD | 1 |
Honnorat, J; Ritzenthaler, T; Verret, JM | 1 |
Foster, CC; Hagge, RJ; Lin, FI; Shelton, DK | 1 |
Guo, WH; Jia, P; Zhang, Y | 1 |
Aukema, TS; Baas, P; Belderbos, JS; Burgers, SA; Klomp, HM; Teertstra, HJ; Valdés Olmos, RA; van den Heuvel, MM; Vogel, WV | 1 |
Boersma, L; Bootsma, G; De Ruysscher, D; Dehing-Oberije, C; Dingemans, AM; Geraedts, W; Hochstenbag, M; Lambin, P; Oellers, M; Pitz, C; Rhami, A; Simons, J; Snoep, G; Teule, J; Thimister, W; van Loon, J; Wanders, R | 1 |
Azad, A; Berlangieri, SU; Chionh, F; Lee, ST; Mitchell, PL; Scott, AM; White, S | 1 |
Hata, Y; Homma, S; Isobe, K; Kaburaki, K; Sakaguchi, S; Takai, Y | 1 |
Gong, H; Huang, W; Lu, Y; Xie, D; Yu, J | 1 |
Hiyama, J; Kaneko, K; Omagari, J; Ono, K; Yoshida, T | 1 |
Abuodeh, Y; Khader, J; Salem, A | 1 |
De Ruysscher, D; Lambin, P; Öllers, M; van Elmpt, W | 1 |
Han, A; Ma, T; Niu, Z; Yu, J; Zhao, S; Zheng, J; Zhu, D | 1 |
Boersma, L; De Ruysscher, D; Lambin, P; Ollers, M; van Baardwijk, A; van Loon, J | 1 |
Steinert, HC | 1 |
De Ruysscher, D | 1 |
Alagoz, E; Arslan, N; Budakoglu, B; Kuzhan, O; Ozet, A; Ozguven, MA; Tuncel, M | 1 |
Faivre-Finn, C; Hulse, P; Lorigan, P; Thomson, D | 1 |
De Ruysscher, D; Dingemans, AM; Lambin, P; Offermann, C; Ollers, M; Rahmy, A; van Elmpt, W; van Loon, J; Vegt, E | 1 |
Apfaltrer, P; Chu, TQ; Dinter, DJ; Fink, C; Henzler, T; Krissak, R; Manegold, C; Meyer, M; Nance, JW; Schmid-Bindert, G; Schoenberg, SO; Schoepf, UJ | 1 |
de Koning, HJ; Groen, HJ; Lammers, JW; Mali, W; Nackaerts, K; Oudkerk, M; Thunnissen, FB; van Klaveren, RJ; van't Westeinde, SC; Vernhout, R; Weenink, C | 1 |
Aerts, JG; Baas, J; Hoogsteden, HC; Smit, EF; van der Leest, C; van Walree, N; Versteijlen, RJ | 1 |
Choi, EK; Choi, WH; Han, EJ; Oh, JK; Park, HL; Song, JS; Yoo, IeR | 1 |
Bom, HS; Chong, A; Kim, YC; Min, JJ; Oh, JR; Seo, JH; Song, HC | 1 |
Endo, S; Endo, T; Hasegawa, T; Ishikawa, S; Kanai, Y; Mitsuda, S; Nakano, T; Otani, S; Saito, N; Tetsuka, K; Tezuka, Y; Yamamoto, S | 1 |
Ceresoli, GL | 1 |
Bae, WK; Kim, YH; Lee, HS; Lee, JW; Lee, SM | 1 |
Kato, K; Okada, M; Saga, T; Sudo, H; Sugyo, A; Tsuji, AB; Wakizaka, H; Yoshida, C; Zhang, MR | 1 |
Kim, EK; Kim, HO; Kim, SW; Lee, DH; Ryu, JS; Sohn, BS; Suh, C; Yoon, DH | 1 |
Li, M; Liu, Q; Peng, Z; Sun, J; Yao, S | 1 |
Al-Harbi, AS; Al-Jahdali, H; Khan, AN; Loutfi, S | 1 |
Bong, JS; Cheng, V; Chundru, S; Fink-Bennett, D; Gaskill, M; Grills, I; Kestin, L; Martinez, AA; Schmidt, J; Wong, CY; Yan, D | 1 |
10 review(s) available for fluorodeoxyglucose f18 and Small Cell Lung Carcinoma
Article | Year |
---|---|
[A Resected Case of Mesenteric Nodal Metastases from Small Cell Lung Carcinoma].
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Small Cell Lung Carcinoma | 2022 |
The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Small Cell Lung Carcinoma | 2021 |
Prognostic value of the maximum standardized uptake value of pre-treatment primary lesions in small-cell lung cancer on 18F-FDG PET/CT: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2018 |
Prognostic value of metabolic tumour volume and total lesion glycolysis measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in small cell lung cancer: A systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tumor Burden | 2019 |
Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-DGlucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Molecular Imaging; Positron-Emission Tomography; Radiation Oncology; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2019 |
Imaging and management of a small cell lung cancer metastasis/adrenal adenoma collision tumor: a case report and review of the literature.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Combination of intravitreal bevacizumab and systemic therapy for choroidal metastases from lung cancer: report of two cases and a systematic review of literature.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Choroid Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Intravitreal Injections; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
18F-FDG PET or PET/CT for detecting extensive disease in small-cell lung cancer: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Therapeutic implications of molecular imaging with PET in the combined modality treatment of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiotherapy, Adjuvant; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome | 2011 |
The role of positron emission tomography in management of small cell lung cancer.
Topics: Biomarkers, Pharmacological; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Treatment Outcome | 2011 |
3 trial(s) available for fluorodeoxyglucose f18 and Small Cell Lung Carcinoma
Article | Year |
---|---|
Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Time Factors; Tomography, X-Ray Computed | 2013 |
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Fiber Optic Technology; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mass Screening; Middle Aged; Patient Selection; Positron-Emission Tomography; Radiation Dosage; Research Design; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
SUVmax during 18FDG-PET scanning in small cell lung cancer: similar information as in non-small cell lung cancer?
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Survival Rate | 2012 |
92 other study(ies) available for fluorodeoxyglucose f18 and Small Cell Lung Carcinoma
Article | Year |
---|---|
Distant Metastasis Patterns of Lung Cancer on Positron Emission Tomography/Computed Tomography Association with Age and Histological Subtype.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma | 2021 |
Thyroid Metastasis in Whole-Body 18F-FDG PET/CT Restaging of Small Cell Lung Cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Thyroid Gland | 2022 |
Editorial Comment: Evolving Indications for FDG PET/MRI in Lung Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Small Cell Lung Carcinoma | 2022 |
A Frequently Missed Pulmonary Infarction: Clinical and 18F-FDG PET/CT Manifestation of Hilar Tumor-Induced Pulmonary Infarction.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Pulmonary Infarction; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
Predictive value of quantitative metabolic tumor volume and metabolic index analysis in lung cancer stereotactic radiotherapy with F-18 FDG PET/CT.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma; Tomography, X-Ray Computed; Tumor Burden | 2022 |
What is the effect of tumor diameter, lymph node metastases, and SUVmax value on prognosis in limited-stage small cell lung cancer?
Topics: Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
Contribution of F-18 fluorodeoxyglucose PET/CT and contrast-enhanced thoracic CT texture analyses to the differentiation of benign and malignant mediastinal lymph nodes.
Topics: Adenocarcinoma; Bayes Theorem; Carcinoma, Squamous Cell; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2023 |
A suspected case of intertrabecular systemic bone metastasis of small-cell lung cancer.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2023 |
18FDG PET/CT Tumoral and Neurologic Therapeutic Response in a Case of Anti-GABABR Paraneoplastic Limbic Encephalitis.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Limbic Encephalitis; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma | 2023 |
Primary tumor SUV
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma | 2023 |
Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2023 |
Small Cell Carcinoma of the Ureter With Early Recurrence and Multiple Metastases Shown on 18 F-FDG PET/CT.
Topics: Adult; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma; Ureter | 2023 |
The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Cisplatin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Limbic Encephalitis; Lung Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma; Treatment Outcome; Whole Body Imaging | 2019 |
Prognostic value of
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Tumor Burden | 2020 |
Rare case: paraneoplastic syndrome affecting peripheral nerves, associated with anti-collapsin-response mediator protein-5 (anti-CRMP5) antibodies, as early manifestation of small cell lung cancer confined to a solitary lymph node without evidence of lung
Topics: Aged; Autoantibodies; Bronchoscopy; Female; Fluorodeoxyglucose F18; Humans; Hydrolases; Lymph Nodes; Microtubule-Associated Proteins; Paraneoplastic Syndromes; Peripheral Nerves; Positron-Emission Tomography; Small Cell Lung Carcinoma; Thorax; Tomography, X-Ray Computed | 2020 |
Risk stratification of symptomatic brain metastases by clinical and FDG PET parameters for selective use of prophylactic cranial irradiation in patients with extensive disease of small cell lung cancer.
Topics: Brain Neoplasms; Cranial Irradiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Risk Assessment; Small Cell Lung Carcinoma | 2020 |
Pilot Study: Texture Analysis of PET Imaging Demonstrates Changes in
Topics: Brain; Brain Neoplasms; Cranial Irradiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pilot Projects; Positron-Emission Tomography; Small Cell Lung Carcinoma | 2021 |
FDG PET Unveils the Course of Paraneoplastic Cerebellar Degeneration: A Semiquantitative Analysis.
Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Small Cell Lung Carcinoma | 2021 |
Paraneoplastic Limbic Encephalitis Secondary to SCLC on 18F-FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Limbic Encephalitis; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma | 2021 |
Prognostic value of pre-treatment
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma | 2017 |
Correlation analysis of [
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Small Cell Lung Carcinoma | 2017 |
Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on
Topics: Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Small Cell Lung Carcinoma; Tumor Burden | 2018 |
Vocal fold paralysis on positron emission tomography-CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma; Vocal Cord Paralysis; Vocal Cords | 2018 |
Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers.
Topics: Adult; Aged; Area Under Curve; Biomarkers, Tumor; Carcinoma, Squamous Cell; DNA Mutational Analysis; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Mutation; Positron Emission Tomography Computed Tomography; Regression Analysis; Retrospective Studies; Small Cell Lung Carcinoma | 2017 |
Case report of
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multiple Endocrine Neoplasia; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma | 2018 |
[Prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in extensive-stage small cell lung cancer].
Topics: Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Tumor Burden | 2017 |
The gamma-aminobutyric acid-B receptor (GABAB) encephalitis: clinical manifestations and response to immunotherapy.
Topics: Aged; Antibodies; Electroencephalography; Encephalitis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunotherapy; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Receptors, GABA-B; Small Cell Lung Carcinoma | 2018 |
Intense 18F-FDG activity in aortoiliac bypass graft mimicking infection: A case report.
Topics: Aged; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Iliac Artery; Incidental Findings; Lung Neoplasms; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Small Cell Lung Carcinoma; Vascular Grafting | 2018 |
Prognostic significance of
Topics: Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis | 2018 |
Performance Comparison Between
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2018 |
Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC).
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Lymphocytes; Male; Middle Aged; Neutrophils; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Tumor Burden | 2019 |
The Value of
Topics: Bone and Bones; Carcinoembryonic Antigen; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Spinal Neoplasms | 2019 |
Fluorine-18-fluorodeoxyglucose-positron emission tomography evaluation in metastatic bone lesions in lung cancer: Possible prediction of pain and skeletal-related events.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cancer Pain; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2019 |
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study.
Topics: Adult; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Italy; Kaplan-Meier Estimate; Male; Neoplasm Staging; Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Small Cell Lung Carcinoma | 2019 |
Prognostic value of metabolic parameters on baseline 18F-FDG PET/CT in small cell lung cancer.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Tumor Burden | 2022 |
Therapy response evaluation with FDG-PET/CT in small cell lung cancer: a prognostic and comparison study of the PERCIST and EORTC criteria.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2013 |
Clinical applicability of staging small cell lung cancer according to the seventh edition of the TNM staging system.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Tomography, X-Ray Computed | 2013 |
High performance of F-fluorodeoxyglucose positron emission tomography and contrast-enhanced CT in a rapid outpatient diagnostic program for patients with suspected lung cancer.
Topics: Aged; Ambulatory Care; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Impact of PET staging in limited-stage small-cell lung cancer.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Survival Rate | 2013 |
FDG uptake in the chest wall of a patient with small-cell lung cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Thoracic Wall | 2013 |
Extra-thoracic tumor burden but not thoracic tumor burden on (18)F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Thoracic Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2013 |
[Sensitivity of PET with 18F-fluorodesoxyglucose in the diagnosis of neuroendocrine tumors of the lungs].
Topics: Adult; Aged; Carcinoid Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2013 |
Iris metastasis in a patient with small cell lung cancer: incidental detection with 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Iris Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
The clinical impact of the sum of the maximum standardized uptake value on the pretreatment with F-FDG-PET/CT in small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma | 2014 |
Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiat
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemoradiotherapy; Cisplatin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proto-Oncogene Proteins c-bcl-2; Radiopharmaceuticals; Small Cell Lung Carcinoma; Survival Rate; Tomography, X-Ray Computed | 2014 |
Correlation of (18)F-FDG avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer.
Topics: Aged; Aged, 80 and over; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Conformal; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Roles of Ki-67, p53, transforming growth factor-β and lysyl oxidase in the metastasis of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Protein-Lysine 6-Oxidase; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed; Transforming Growth Factor beta; Tumor Suppressor Protein p53 | 2014 |
Correlation of 18F-FDG PET avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer. In regard to Shusharina et al.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2014 |
Correlation of 18F-FDG PET avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer. In reply to Saraiya et al.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2014 |
Prognostic value of volumetric metabolic parameters measured by [18F]fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Can EBUS-TBNA provide an accurate diagnosis in patients found to have enlarged or FDG-avid lymph nodes during surveillance of previously treated lung cancer? A retrospective study.
Topics: Adenocarcinoma; Aged; Bronchoscopy; Carcinoma, Squamous Cell; Databases, Factual; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2015 |
A Case of Massive Bone Metastases From Lung Cancer Detected Only by 18F-FDG PET/CT.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2015 |
Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer.
Topics: Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Tumor Burden | 2016 |
FDG PET/CT allowing detection and follow-up of tumor cell transplantation.
Topics: Cell Transplantation; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma | 2016 |
The Role of 18F-FDG PET/CT on Staging and Prognosis in Patients with Small Cell Lung Cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma | 2016 |
Prognostic value of fluorine-18 fludeoxyglucose positron emission tomography parameters differs according to primary tumour location in small-cell lung cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Small Cell Lung Carcinoma | 2016 |
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience.
Topics: Adult; Aged; Coordination Complexes; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Middle Aged; Octreotide; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Receptors, CXCR4; Receptors, Somatostatin; Small Cell Lung Carcinoma | 2016 |
The Highest Metabolic Activity on FDG PET Is Associated With Overall Survival in Limited-Stage Small-Cell Lung Cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Small Cell Lung Carcinoma | 2016 |
Prognostic significance of standardised uptake value (SUV
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Retrospective Studies; Serum Albumin; Small Cell Lung Carcinoma | 2017 |
Pretreatment metabolic parameters measured by 18F-FDG-PET to predict the outcome of first-line chemotherapy in extensive-stage small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome; Tumor Burden; Young Adult | 2017 |
Detection of an asymptomatic right-ventricle cardiac metastasis from a small-cell lung cancer by F-18-FDG PET/CT.
Topics: Aged; Antineoplastic Agents; Combined Modality Therapy; Fatal Outcome; Fluorodeoxyglucose F18; Heart Neoplasms; Heart Ventricles; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
[The role of (18)F-FDG DHC SPECT-CT in the diagnosis and staging for lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2009 |
Chorea, transverse myelitis, neuropathy and a distinctive MRI: paraneoplastic manifestations of probable small cell lung cancer.
Topics: Aged; Chorea; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Myelitis, Transverse; Peripheral Nervous System Diseases; Positron-Emission Tomography; Small Cell Lung Carcinoma | 2009 |
[Paraneoplastic chorea and behavioral disorders in a patient with anti-CV2/CRMP5 antibodies and two different tumors].
Topics: Aged, 80 and over; Autoantibodies; Chorea; Dyslipidemias; Electrodiagnosis; Fluorodeoxyglucose F18; Humans; Hydrolases; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Mental Disorders; Microtubule-Associated Proteins; Myocardial Infarction; Nerve Tissue Proteins; Obsessive-Compulsive Disorder; Paraneoplastic Polyneuropathy; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2010 |
Extensive FDG uptake in accessory muscles of respiration in a patient with shortness of breath.
Topics: Abdominal Muscles; Aged; Dyspnea; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Respiratory Muscles; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
[Clinical significance of (18)F-FDG PET-CT in evaluation of the therapeutic efficacy of chemotherapy for lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
Evaluation of (18)F-FDG PET-CT for differentiation of pulmonary pathology in an approach of outpatient fast track assessment.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Irradiation; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Small Cell Lung Carcinoma; Survival Analysis; Tomography, X-Ray Computed | 2010 |
High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2010 |
[Efficacy of fluoro-2-deoxyglucose positron emission tomography imaging in response evaluation of patients with small cell lung cancer (pilot study)].
Topics: Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2009 |
18F-FDG PET/CT in the evaluation of adrenal masses in lung cancer patients.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adult; Aged; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2010 |
Chest wall and axillary lymph node FDG uptake associated with cancer vaccine therapy for lung cancer.
Topics: Aged; Axilla; Cancer Vaccines; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Positron-Emission Tomography; Recurrence; Small Cell Lung Carcinoma; Thoracic Wall; Tomography, X-Ray Computed | 2010 |
Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. In regard to van Loon et al. (Int J Radiat Oncol Biol Phys 2010;77:329-336).
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Irradiation; Mediastinum; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2010 |
Should patient setup in lung cancer be based on the primary tumor? An analysis of tumor coverage and normal tissue dose using repeated positron emission tomography/computed tomography imaging.
Topics: Aged; Aged, 80 and over; Anatomic Landmarks; Bone and Bones; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Multimodal Imaging; Organs at Risk; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Small Cell Lung Carcinoma; Spinal Cord; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Tomography, Emission-Computed | 2011 |
PET and PET-CT of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, Emission-Computed | 2011 |
PET-CT in radiotherapy for lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, Emission-Computed | 2011 |
Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis | 2011 |
Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Combined Modality Therapy; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Iodine; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2012 |
The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial.
Topics: Adenocarcinoma; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mass Screening; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Small Cell Lung Carcinoma; Survival Rate | 2011 |
Acute appendicitis secondary to metastatic small cell lung cancer incidentally found on F-18 FDG PET/CT.
Topics: Acute Disease; Appendiceal Neoplasms; Appendicitis; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2012 |
Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2012 |
[Clinicopathological study of small lung cancer (diameter of 2 cm or less) by uptake value of 18F-fluorodeoxyglucose].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2012 |
FDG PET/CT metabolic tumour volume in small-cell lung cancer: better staging and prognostic stratification for an improved therapeutic strategy.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Small Cell Lung Carcinoma; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
Topics: Aged; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2012 |
Comparison of 2-amino-[3-¹¹C]isobutyric acid and 2-deoxy-2-[¹⁸F]fluoro-D-glucose in nude mice with xenografted tumors and acute inflammation.
Topics: Acute Disease; Aminoisobutyric Acids; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Stability; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Male; Mice; Mice, Nude; Positron-Emission Tomography; Small Cell Lung Carcinoma | 2012 |
The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma; Systems Integration; Tomography, X-Ray Computed | 2012 |
Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cell Proliferation; Choline; Choline Kinase; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2013 |
Guidelines for the role of FDG-PET/CT in lung cancer management.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2012 |
Correlating metabolic and anatomic responses of primary lung cancers to radiotherapy by combined F-18 FDG PET-CT imaging.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Theoretical; Positron-Emission Tomography; Radiotherapy; Reproducibility of Results; Small Cell Lung Carcinoma; Time Factors; Tomography, X-Ray Computed | 2007 |